Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ScNMT-seq of pancreatic organoids - DNA methylation and chromatin accessibility

ABSTRACT: scNMT-seq of pancreatic organoids - DNA methylation and chromatin accessibility

PROVIDER: PRJNA867583 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

scNMT-seq of pancreatic organoids - DNA methylation and chromatin accessibility

Project description:Single-cell nucleosome, methylome and transcriptome (scNMT) sequencing is a recently developed method that allows multiomics profiling of single cells. In this scNMT protocol, we describe profiling of cells from mouse brain and pancreatic organoids, using liquid handling platforms to increase throughput from 96-well to 384-well plate format. Our approach miniaturizes reaction volumes and incorporates the latest Smart-seq3 protocol to obtain a higher number of detected genes and genomic DNA (gDNA) CpG sites per cell. We outline normalization steps to optimally distribute per-cell sequencing depth.

2022-08-12 | GSE210804 | GEO

scNMT-seq of pancreatic organoids - RNA

2022-08-12 | GSE210805 | GEO

scNMT-seq of pancreatic organoids - RNA

Project description:scNMT-seq of pancreatic organoids - RNA

| PRJNA867584 | ENA

scNMT-seq of the adult NSC lineage - DNA methylation and chromatin accessibility

Project description:scNMT-seq of the adult NSC lineage - DNA methylation and chromatin accessibility

| PRJNA872122 | ENA

scNMT-seq enables joint profiling of chromatin accessibility DNA methylation and transcription in single cells.

Project description:Parallel single-cell sequencing protocols represent powerful methods for investigating regulatory relationships, including epigenome-transcriptome interactions. Here, we report a single-cell method for parallel chromatin accessibility, DNA methylation and transcriptome profiling. scNMT-seq (single-cell nucleosome, methylation and transcription sequencing) uses a GpC methyltransferase to label open chromatin followed by bisulfite and RNA sequencing. We validate scNMT-seq by applying it to differentiating mouse embryonic stem cells, finding links between all three molecular layers and revealing dynamic coupling between epigenomic layers during differentiation.

| S-EPMC5823944 | biostudies-literature

Joint profiling of chromatin accessibility, DNA methylation and transcription in single cells

Project description:Parallel single-cell sequencing protocols represent powerful methods for investigating regulatory relationships, including epigenome-transcriptome interactions. Here, we report the first single-cell method for parallel chromatin accessibility, DNA methylation and transcriptome profiling. scNMT-seq (single-cell nucleosome, methylation and transcription sequencing) uses a GpC methyltransferase to label open chromatin followed by bisulfite and RNA sequencing. We validate scNMT-seq by applying it to differentiating mouse embryonic stem cells, finding links between all three molecular layers and revealing dynamic coupling between epigenomic layers during differentiation.

2018-01-17 | GSE109262 | GEO

Integrated profiling of human pancreatic cancer organoids reveals chromatin accessibility features associated with drug sensitivity

Project description:Chromatin accessibility plays an essential role in controlling cellular identity and the therapeutic response of human cancers. However, the chromatin accessibility landscape and gene regulatory network of pancreatic cancer are largely uncharacterized. Here, we integrate the chromatin accessibility profiles of 84 pancreatic cancer organoid lines with whole-genome sequencing data, transcriptomic sequencing data and the results of drug sensitivity analysis of 283 epigenetic-related chemicals and 5 chemotherapeutic drugs. We identify distinct transcription factors that distinguish molecular subtypes of pancreatic cancer, predict numerous chromatin accessibility peaks associated with gene regulatory networks, discover novel regulatory noncoding mutations with potential as cancer drivers, and reveal the chromatin accessibility signatures associated with drug sensitivity. These results not only provide the chromatin accessibility atlas of pancreatic cancer but also suggest a systematic approach to comprehensively understand the gene regulatory network of pancreatic cancer in order to advance diagnosis and potential personalized medicine applications.

2022-02-23 | GSE194249 | GEO

Integrated profiling of human pancreatic cancer organoids reveals chromatin accessibility features associated with drug sensitivity (ATAC-Seq data).

2022-02-23 | GSE195623 | GEO

Integrated profiling of human pancreatic cancer organoids reveals chromatin accessibility features associated with drug sensitivity

Project description:Integrated profiling of human pancreatic cancer organoids reveals chromatin accessibility features associated with drug sensitivity

| PRJNA799993 | ENA

Pancreatic cancer prognosis is predicted by chromatin accessibility

Project description:Pancreatic cancer prognosis is predicted by chromatin accessibility

| PRJNA511018 | ENA